May 5, 2019

Avanti Biosciences is awarded the second phase of the fast track SBIR grants from the NIA for work on Alzheimer's Disease.

July 30, 2018

Avanti Biosciences receives $300,000 SBIR Phase 1 grant from the NIDDK for the development of new therapies for the treatment of Hyperinsulinemia Hyperammonemia Syndrome in collaboration with the Children Hospital of Philadelphia (CHOP)

May 1, 2018

Avanti Biosciences open new operations in the JLAB San Diego.

August 15, 2017

Avanti Biosciences Receives $1.9M SBIR Fast-Track Award to Further Treatment for Alzheimer’s Disease

October 8, 2015

Avanti Biosciences approved by the Long Island High Technology Incubator (LIHTI) as part of the Incubator Without Walls Program initiative.

Call

T: 858-242-1570

F: 631.967.1507

 

Contact

3210 Merryfield Row

San Diego, CA 92121-1126

information@AvantiBiosciences.com

Avanti Biosciences Inc.